Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Countries and organisations
Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.
Free access · No subscription for research tools or data exports
Explore registry geography and organisations
3 trials match this view; 8 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 80 across 3 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsHealthy Volunteer · Older Adults (65-85 Years) | University of Colorado, Denver PHASE1 | Recruiting Registry updated 2026-09-16 | 40 ESTIMATED | 2026-04-01 2028-03 2028-03 | |
| Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in RemissionBreast Cancer · Ovarian Cancer | University of Colorado, Denver PHASE1 | Recruiting Registry updated 2026-09-04 | 20 ESTIMATED | 2024-11-21 2026-12 2028-12 | |
| Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot TrialMajor Depressive Disorder · Anhedonia · Treatment Resistant Depression | University of Colorado, Denver PHASE2 | Completed Registry updated 2026-05-22 | 20 ACTUAL | 2024-07-08 2026-05-08 2026-05-08 |
Reported research facilities
University of California San Francisco (UCSF) Department of NeurologySan Francisco, California, United States
University of Colorado Anschutz Medical CampusAurora, Colorado, United States
Emory University Brain Health CenterAtlanta, Georgia, United States
Dana-Farber Cancer InstituteBoston, Massachusetts, United States
University of Nebraska Medical CenterOmaha, Nebraska, United States
New York University Langone Health, Center for Psychedelic MedicineNew York, New York, United States
Outpatient CTRCAurora, Colorado, United States
University of Colorado Cancer CenterAurora, Colorado, United States
This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.